SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Mar-24 5:20 PM View: | Outlook Therapeutics, Inc. (OTLK) | 18-Mar-24 | Grant | 2,305,710 | -- | -- | 66% 3.5M to 5.81M | |
29-Dec-22 5:01 PM View: | Outlook Therapeutics, Inc. (OTLK) | 28-Dec-22 | Grant | 14,230,400 | $0.88 | $12,500,000.00 | 25% 55.82M to 70.05M | |
01-Feb-22 5:05 PM View: | Outlook Therapeutics, Inc. (OTLK) | 01-Feb-22 | Acquisition (other) | 2,500,000 | $1.25 | $3,125,000.00 | 5% 53.32M to 55.82M | |
01-Dec-21 7:32 PM View: | Outlook Therapeutics, Inc. (OTLK) | 29-Nov-21 | Private Purchase | 16,000,000 | $1.25 | $20,000,000.00 | 25% 62.8M to 78.8M | |
11-Feb-21 5:46 PM View: | Outlook Therapeutics, Inc. (OTLK) | 10-Feb-21 | Grant | 1,013,630 | $1.00 | $1,013,630.00 | 2% 61.79M to 62.8M | |
02-Feb-21 5:32 PM View: | Outlook Therapeutics, Inc. (OTLK) | 02-Feb-21 | Private Purchase | 8,360,000 | $1.00 | $8,360,000.00 | 35% 24.07M to 32.43M | 13% |
27-Feb-20 10:00 PM View: | Outlook Therapeutics, Inc. (OTLK) | 26-Feb-20 | Grant | 2,460,630 | $1.02 | $2,500,000.00 | 11% 21.61M to 24.07M |